secwatch.observer — SEC 8-K summary
======================================

Issuer:     DMK PHARMACEUTICALS Corp (—)
CIK:        0000887247
Form:       8-K
Filed at:   2024-02-05T23:59:59+00:00
Accession:  0001839882-24-003361
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DMK Pharmaceuticals files Chapter 11; expects Nasdaq delisting, stock may become worthless
--------------------------------------------------------------------------------

- Filed voluntary Chapter 11 petitions on Feb 2, 2024 in Delaware Bankruptcy Court.
- Will operate as debtor-in-possession; seeks court approval to continue paying wages, salaries, benefits.
- Expects Nasdaq delisting notice; will not appeal, so common stock will be delisted.
- Caution: trading in securities highly speculative; stockholders could experience significant or complete loss.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887247/000183988224003361/0001839882-24-003361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887247/000183988224003361/dmk-8k_020524.htm
  HTML page:      https://secwatch.observer/filing/0001839882-24-003361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer